Cargando…
ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease with pathophysiological characteristics of transforming growth factor-β (TGF-β), and reactive oxygen species (ROS)-induced excessive fibroblast-to-myofibroblast transition and extracellular matrix deposition. Macrophag...
Autores principales: | Liu, Junzhao, Wu, Zuohong, Liu, Yadong, Zhan, Zhu, Yang, Liping, Wang, Can, Jiang, Qinqin, Ran, Haitao, Li, Pan, Wang, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074278/ https://www.ncbi.nlm.nih.gov/pubmed/35524280 http://dx.doi.org/10.1186/s12951-022-01435-4 |
Ejemplares similares
-
Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
por: Liu, Ying, et al.
Publicado: (2022) -
Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis
por: Wang, Zixiao, et al.
Publicado: (2023) -
Photosynthesis-inspired H(2) generation using a chlorophyll-loaded liposomal nanoplatform to detect and scavenge excess ROS
por: Wan, Wei-Lin, et al.
Publicado: (2020) -
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018) -
Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms
por: Ferreira, Magda, et al.
Publicado: (2021)